Identify Bacteria Associated With Metabolic Diseases That Reside Both in Intestinal Crypts and in Blood
NCT ID: NCT02261831
Last Updated: 2018-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
99 participants
INTERVENTIONAL
2014-02-28
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome
NCT02851602
Study of the Intestinal Microbiota During a Real Life Dietary Intervention in Subjects With Overweight or Obesity
NCT04822948
A Biological Atlas of Severe Obesity (Biological Tissue Collection)
NCT01129297
Gut Microbiome and Obesity
NCT04451148
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
obese patients
Total blood sample, and 4 biopsies : collection of 2 colonic and 2 ileal biopsies
obese patients
collection of blood sampling and biopsies
Diabetic patients
Total blood sample, and 4 biopsies : collection of 2 colonic and 2 ileal biopsies
diabetic patients
collection of blood sampling and biopsies
Patients free of obesity and diabetes
Total blood sample, and 4 biopsies : collection of 2 colonic and 2 ileal biopsies
patients free of obesity and diabetes
collection of blood sampling and biopsies
patients free type 2 diabetes.
Total blood sample, and 4 biopsies : collection of 2 colonic and 2 ileal biopsies
patients free type 2 diabetes
collection of blood sampling and biopsies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
obese patients
collection of blood sampling and biopsies
diabetic patients
collection of blood sampling and biopsies
patients free of obesity and diabetes
collection of blood sampling and biopsies
patients free type 2 diabetes
collection of blood sampling and biopsies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Colonoscopy and biopsies required
Diabetes population:
* Type 2 diabetes
Obese population:
* Android obesity
Exclusion Criteria
* Colonic cancer
* Bariatric surgery
* Previous administration of antibiotic (within 15 days)
* Pregnancy
35 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Toulouse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacques AMAR, MD PhD
Role: STUDY_DIRECTOR
University Hospital, Toulouse
Jacques Moreau, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Toulouse
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13 6936 03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.